I was unable to find specific information on Yervoy's discount terms. However, I can provide some context about the drug and potential discounts that may be available.
Yervoy (ipilimumab) is a monoclonal antibody used to treat melanoma, a type of skin cancer. It is manufactured by Bristol Myers Squibb and was approved by the FDA in 2011 [1]. The drug works by stimulating the immune system to attack cancer cells [2].
There are several ways to access discounts on Yervoy:
1. **Patient Assistance Programs (PAPs)**: Bristol Myers Squibb offers a patient assistance program for eligible patients who cannot afford their medications [3]. The program provides Yervoy at no cost to eligible patients who meet the income and insurance requirements.
2. **Bristol Myers Squibb's Patient Support Source**: This program offers personalized support for patients, including help with insurance, financial assistance, and treatment support [4].
3. **Co-pay Assistance Programs**: Some organizations offer co-pay assistance programs for patients taking Yervoy. For example, the Patient Access Network Foundation provides co-pay assistance for eligible patients with a household income up to 500% of the federal poverty level [5].
4. **State Pharmaceutical Assistance Programs (SPAPs)**: Some states offer pharmaceutical assistance programs for eligible residents. These programs may provide discounts on Yervoy or other medications [6].
5. **Medicaid and Medicare**: These government-funded health insurance programs may cover Yervoy for eligible patients. Medicaid and Medicare patients may be responsible for co-pays or deductibles [7].
It's important to note that eligibility for these programs may vary based on factors such as income, insurance status, and residency. Patients should contact the programs directly for more information on discounts and eligibility requirements.
Sources:
1. FDA. (2011). FDA approves Yervoy, first drug to improve survival in advanced melanoma. <https://www.fda.gov/news-events/press-announcements/fda-approves-yervoy-first-drug-improve-survival-advanced-melanoma>
2. National Cancer Institute. (2021). Ipilimumab. <https://www.cancer.gov/about-cancer/treatment/drugs/ipilimumab>
3. Bristol Myers Squibb. (2021). BMS Patient Assistance Foundation, Inc. <https://www.bms.com/patients/patient-assistance.html>
4. Bristol Myers Squibb. (2021). Patient Support Source. <https://www.bms.com/patients/patient-support-source.html>
5. Patient Access Network Foundation. (2021). Ipilimumab. <https://www.panfoundation.org/ipilimumab/>
6. National Conference of State Legislatures. (2021). State Pharmaceutical Assistance Programs (SPAPs). <https://www.ncsl.org/research/health/state-pharmaceutical-assistance-programs-spaps.aspx>
7. Medicaid.gov. (2021). Covered Drugs. <https://www.medicaid.gov/medicaid/prescription-drugs/index.html>
8. Medicare.gov. (2021). Medicare drug coverage (Part D). <https://www.medicare.gov/drug-coverage-part-d>